Cleared Special

K253609 - TRAUMAGEL® 2.0 Hemostatic Gel (FDA 510(k) Clearance)

Dec 2025
Decision
24d
Days
-
Risk

K253609 is an FDA 510(k) clearance for the TRAUMAGEL® 2.0 Hemostatic Gel. This device is classified as a Hemostatic Wound Dressing Without Thrombin Or Other Biologics.

Submitted by Cresilon, Inc. (Brooklyn, US). The FDA issued a Cleared decision on December 12, 2025, 24 days after receiving the submission on November 18, 2025.

This device falls under the General & Plastic Surgery FDA review panel. To Temporarily Control Bleeding And Cover External Wounds..

Submission Details

510(k) Number K253609 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2025
Decision Date December 12, 2025
Days to Decision 24 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QSY - Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class -
Definition To Temporarily Control Bleeding And Cover External Wounds.